Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Yasuyuki KOJIMA"'
Autor:
Satoi Nagasawa, Yuta Kuze, Ichiro Maeda, Yasuyuki Kojima, Ai Motoyoshi, Tatsuya Onishi, Tsuguo Iwatani, Takamichi Yokoe, Junki Koike, Motohiro Chosokabe, Manabu Kubota, Hibiki Seino, Ayako Suzuki, Masahide Seki, Katsuya Tsuchihara, Eisuke Inoue, Koichiro Tsugawa, Tomohiko Ohta, Yutaka Suzuki
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Satoi Nagasawa and Yuta Kuze et al. report a multi-omic analysis of ductal carcinoma in situ (DCIS) of the breast, including whole-exome, single-cell, and spatial transcriptome sequencing. They find that for patients under 45 years of age, HER2 ampli
Externí odkaz:
https://doaj.org/article/e426aed0800f44f79e31480b616c2d54
Autor:
Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background Trastuzumab (Tmab), pertuzumab (Pmab), and taxane has been a standard first-line treatment for recurrent or metastatic human epidermal growth factor (HER2)-positive breast cancer (HER2+ mBC) but has some safety issues due to taxan
Externí odkaz:
https://doaj.org/article/13394829294f4820b6b1ee9b18116f5f
Autor:
Tsutomu Iwasa, Junji Tsurutani, Satomi Watanabe, Ryoji Kato, Yutaka Mizuno, Yasuyuki Kojima, Tsutomu Takashima, Nobuki Matsunami, Takashi Morimoto, Jun Yamamura, Shoichiro Ohtani, Yuko Tanabe, Tetsuhiro Yoshinami, Toshimi Takano, Yoshifumi Komoike, Kazuhiko Nakagawa
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background We previously reported the synergistic effect of S-1 and eribulin in preclinical models. In addition, our phase I study revealed the recommended dose for the phase II study of the combination therapy in advanced breast cancer (ABC
Externí odkaz:
https://doaj.org/article/0a03588daea444e08474b844baa4c3b0
Autor:
Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-2 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/bd2ab67ee9e74891b60121739b47389a
Autor:
Keiichiro Tada, Hiraku Kumamaru, Hiroaki Miyata, Sota Asaga, Kotaro Iijima, Etsuyo Ogo, Takayuki Kadoya, Makoto Kubo, Yasuyuki Kojima, Kenta Tanakura, Kenji Tamura, Masayuki Nagahashi, Naoki Niikura, Naoki Hayashi, Minoru Miyashita, Masayuki Yoshida, Shinji Ohno, Shigeru Imoto, Hiromitsu Jinno
Publikováno v:
Breast Cancer. 30:157-166
Information regarding patients who were treated for breast cancer in 2018 was extracted from the National Clinical Database (NCD), which is run by Japanese physicians. This database continues from 1975, created by the Japanese Breast Cancer Society (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70da727dd8b7175f4b0ce6752d9c83e3
https://doi.org/10.1007/s12282-022-01423-4
https://doi.org/10.1007/s12282-022-01423-4
Autor:
Chihiro Udagawa, Sherwin Kuah, Tatsunori Shimoi, Ken Kato, Teruhiko Yoshida, Mari Hara Nakano, Arata Shimo, Yasuyuki Kojima, Reiko Yoshie, Koichiro Tsugawa, Taisei Mushiroda, Ern Yu Tan, Hitoshi Zembutsu
Publikováno v:
Biologicalpharmaceutical bulletin. 45(8)
Trastuzumab (herceptin) is an effective drug for human epidermal growth factor receptor type 2 (HER2)-positive cancer. However, cardiotoxicity remains a serious complication. In our previous genome-wide association study (GWAS), we identified potenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73a7b1d126ac51447d5747269b9e3120
https://pubmed.ncbi.nlm.nih.gov/35908902
https://pubmed.ncbi.nlm.nih.gov/35908902
Autor:
Yuka Ito, Koichiro Tsugawa, Marii Suehiro, Masaki Takahashi, Kiwako Ikegawa, Tsuneaki Tanaka, Takayuki Keira, Yasuyuki Kojima, Hiroko Minatogawa
Publikováno v:
Cancer Management and Research
Marii Suehiro,1,* Yasuyuki Kojima,2,* Masaki Takahashi,3,* Yuka Ito,4 Takayuki Keira,1 Kiwako Ikegawa,1 Hiroko Minatogawa,1 Koichiro Tsugawa,2 Tsuneaki Tanaka1 1Department of Pharmacy, St. Marianna University School of Medicine Hospital, Kawasaki-shi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cf41f3de8c7c1c784aad84cc358b78d
https://doi.org/10.2147/cmar.s280995
https://doi.org/10.2147/cmar.s280995
Autor:
Arata Shimo, Ai Motoyoshi, Yoshihide Kanemaki, Hidefumi Mimura, Reiko Yoshie, Yasuyuki Kojima, Koichiro Tsugawa, Hisanori Kawamoto, Ei Haku, Akihiko Suto, Mizuho Tazo, Yukari Yabuki, Mari Hara Nakano, Mamoru Fukuda, Ichiro Maeda, Mariko Takishita, Ayaka Shimo, Ryoko Oi, Takako Kuroda, Tsuguo Iwatani, Tomoko Tsuruga
Publikováno v:
Journal of Cancer Therapy. 12:563-576
Objective: This study aimed to evaluate the feasibility, safety, and cosmetic outcomes of percutaneous cryoablation (PCA) of breast intraductal carcinoma (IDC) lesions, as well as post-cryoablation magnetic resonance imaging (MRI) as a follow-up tool
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8b25512a40ca4ce1ff1ffbf8299d799
https://doi.org/10.4236/jct.2021.1210047
https://doi.org/10.4236/jct.2021.1210047
Autor:
Naoki Hayashi, Ryu Tokui, Koichiro Tsugawa, Yasuyuki Kojima, Mizuho Tazo, Tomoko Ogawa, Atsushi Yoshida, Seigo Nakamura, Naoko Matsuda, Makoto Ishitobi, Sayuka Nakayama, Takahiro Nakayama, Hideko Yamauchi, Takashi Kuwayama
Publikováno v:
Annals of Surgical Oncology. 28:2545-2552
Attention has been focused on attempts to eliminate breast surgery for breast cancer patients who achieve a pathologic complete response after neoadjuvant chemotherapy (NAC). However, there are few data on ipsilateral breast tumor recurrence (IBTR) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c37bfcc03141e330abb20e5da56bc94
https://doi.org/10.1245/s10434-020-09176-0
https://doi.org/10.1245/s10434-020-09176-0
Autor:
Masayuki Yoshida, Kenta Tanakura, Hiraku Kumamaru, Etsuyo Ogo, Masayuki Nagahashi, Hiromitsu Jinno, Kotaro Iijima, Urara Isozumi, Shigeru Imoto, Naoki Hayashi, Minoru Miyashita, Hiroaki Miyata, Kenji Tamura, Takayuki Kadoya, Makoto Kubo, Yutaka Yamamoto, Yasuyuki Kojima, Sota Asaga, Kenjiro Aogi, Naoki Niikura
Publikováno v:
Breast Cancer. 27:803-809
The Japanese Breast Cancer Society Registry started in 1975; it was transferred to the registry platform of the National Clinical Database in 2012. We provide the annual data and an analysis of the Breast Cancer Registry for 2017. Patients’ charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca5606d964f291e52d65490cc64a90b
https://doi.org/10.1007/s12282-020-01139-3
https://doi.org/10.1007/s12282-020-01139-3